FR2822468B1 - CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT - Google Patents

CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT

Info

Publication number
FR2822468B1
FR2822468B1 FR0103916A FR0103916A FR2822468B1 FR 2822468 B1 FR2822468 B1 FR 2822468B1 FR 0103916 A FR0103916 A FR 0103916A FR 0103916 A FR0103916 A FR 0103916A FR 2822468 B1 FR2822468 B1 FR 2822468B1
Authority
FR
France
Prior art keywords
application
chemical derivatives
telomerase agent
telomerase
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0103916A
Other languages
French (fr)
Other versions
FR2822468A1 (en
Inventor
Patrick Mailliet
Abdelazize Laoui
Jean Francois Riou
Gilles Doerflinger
Jean Louis Mergny
Francois Hamy
Thomas Caulfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0103916A priority Critical patent/FR2822468B1/en
Priority to UY27211A priority patent/UY27211A1/en
Priority to CO02025874A priority patent/CO5380035A1/en
Priority to AU2002251140A priority patent/AU2002251140B2/en
Priority to PCT/FR2002/001005 priority patent/WO2002076975A1/en
Priority to ARP020101060A priority patent/AR034297A1/en
Priority to PE2002000227A priority patent/PE20020959A1/en
Priority to EP02720068A priority patent/EP1373252A1/en
Priority to EC2002004236A priority patent/ECSP024236A/en
Priority to IL15805602A priority patent/IL158056A0/en
Priority to CA002442012A priority patent/CA2442012A1/en
Priority to MYPI20021036A priority patent/MY130957A/en
Priority to MXPA03008269A priority patent/MXPA03008269A/en
Priority to JP2002576233A priority patent/JP2004524349A/en
Priority to US10/103,883 priority patent/US6887873B2/en
Publication of FR2822468A1 publication Critical patent/FR2822468A1/en
Priority to IL158056A priority patent/IL158056A/en
Priority to US10/993,637 priority patent/US7482352B2/en
Application granted granted Critical
Publication of FR2822468B1 publication Critical patent/FR2822468B1/en
Priority to US12/335,960 priority patent/US20090226411A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
FR0103916A 2001-03-23 2001-03-23 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT Expired - Fee Related FR2822468B1 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR0103916A FR2822468B1 (en) 2001-03-23 2001-03-23 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT
UY27211A UY27211A1 (en) 2001-03-23 2002-03-15 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT
CO02025874A CO5380035A1 (en) 2001-03-23 2002-03-21 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT
MXPA03008269A MXPA03008269A (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent.
ARP020101060A AR034297A1 (en) 2001-03-23 2002-03-22 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT
PE2002000227A PE20020959A1 (en) 2001-03-23 2002-03-22 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELLOMERASE AGENTS
EP02720068A EP1373252A1 (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent
EC2002004236A ECSP024236A (en) 2001-03-23 2002-03-22 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT
IL15805602A IL158056A0 (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent
CA002442012A CA2442012A1 (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent
AU2002251140A AU2002251140B2 (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent
PCT/FR2002/001005 WO2002076975A1 (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agent
JP2002576233A JP2004524349A (en) 2001-03-23 2002-03-22 Chemical derivatives and their use as anti-telomerase agents
MYPI20021036A MY130957A (en) 2001-03-23 2002-03-22 Triazine derivatives and their application as antitelomerase agents
US10/103,883 US6887873B2 (en) 2001-03-23 2002-03-25 Triazine derivatives and their application as antitelomerase agents
IL158056A IL158056A (en) 2001-03-23 2003-09-22 Chemical derivatives and pharmaceutical compositions containing them for use as anti-telomerase agent
US10/993,637 US7482352B2 (en) 2001-03-23 2004-11-19 Chemical derivatives and their application as antitelomerase agents
US12/335,960 US20090226411A1 (en) 2001-03-23 2008-12-16 Chemical derivatives and their application as antitelomerase agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103916A FR2822468B1 (en) 2001-03-23 2001-03-23 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT

Publications (2)

Publication Number Publication Date
FR2822468A1 FR2822468A1 (en) 2002-09-27
FR2822468B1 true FR2822468B1 (en) 2008-06-20

Family

ID=8861454

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0103916A Expired - Fee Related FR2822468B1 (en) 2001-03-23 2001-03-23 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT

Country Status (3)

Country Link
EC (1) ECSP024236A (en)
FR (1) FR2822468B1 (en)
UY (1) UY27211A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006246958A1 (en) * 2005-05-19 2006-11-23 Prometic Biosciences Inc. Triazine compounds and compositions thereof for the treatment of cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206768D0 (en) * 1992-03-27 1992-05-13 Jarman Michael New compounds for use in the treatment of cancer
JPH1160573A (en) * 1997-08-22 1999-03-02 Nippon Kayaku Co Ltd Triazine derivative and telomerase inhibitor
US6262053B1 (en) * 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
KR20020058043A (en) * 1999-11-29 2002-07-12 추후제출 Arylamine derivatives and their use as anti-telomerase agent

Also Published As

Publication number Publication date
FR2822468A1 (en) 2002-09-27
ECSP024236A (en) 2003-10-28
UY27211A1 (en) 2002-08-30

Similar Documents

Publication Publication Date Title
FR20C1039I2 (en) DERIVATIVES OF UK-2A
NO2019039I1 (en) Denosumab
FR2830516B1 (en) SUSPENSION OF TURBOJET
DE60204857D1 (en) Atomizer
ATE555761T1 (en) ABSORBENT ARTICLE
DE60209850D1 (en) Absorbent article
BR0201972B1 (en) amount of suspension.
DE60111430D1 (en) HYPOCHLORIC ACID COMPOSITION AND ITS USES
EE200300400A (en) Pyrimidine compounds, process for their preparation and use
DE60130046D1 (en) Node selection process
DE60234592D1 (en) AQUEOUS COMPOSITION
IL158056A0 (en) Chemical derivatives and their use as anti-telomerase agent
AU2002251140A1 (en) Chemical derivatives and their use as anti-telomerase agent
AR028607A1 (en) DERIVATIVES OF 1,4-DIAZEPAN-2,5-DIONA
LU90483B1 (en) New compositions of parox-tine m-thanesulfonate
DE60201463D1 (en) Indanon derivatives as fragrances
DE60225446D1 (en) FLAME-PROTECTED COMPOSITION AND ARTICLES
FR2819255B1 (en) CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT
FR2822468B1 (en) CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT
PT1392670E (en) SUBSTITUTED DERIVATIVES OF C-FURAN-2-IL-METHYLAMINE AND C-THIOFEN-2-IL-METHYLAMINE
FR2825090B1 (en) CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT
DE60233072D1 (en) THIOPHEN DERIVATIVES AND THEIR USE AS FRAGRANCES
FR2801588B1 (en) CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT
NO20034972D0 (en) Treatment of ADHD
AU2002229859A1 (en) Chemical derivatives and their use as anti-telomerase agent

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20111130